X-2907437-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000381154.6(ARSD):c.1616C>A(p.Ala539Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000661 in 1,210,336 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 31 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A539T) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000381154.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSD | NM_001669.4 | c.1616C>A | p.Ala539Asp | missense_variant | 10/10 | ENST00000381154.6 | NP_001660.2 | |
ARSD | XM_005274514.3 | c.1481C>A | p.Ala494Asp | missense_variant | 9/9 | XP_005274571.1 | ||
ARSD | XM_047442108.1 | c.1478C>A | p.Ala493Asp | missense_variant | 10/10 | XP_047298064.1 | ||
ARSD | XM_005274515.3 | c.*540C>A | 3_prime_UTR_variant | 10/10 | XP_005274572.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSD | ENST00000381154.6 | c.1616C>A | p.Ala539Asp | missense_variant | 10/10 | 1 | NM_001669.4 | ENSP00000370546.1 | ||
ARSD | ENST00000458014.1 | c.422C>A | p.Ala141Asp | missense_variant | 3/4 | 3 | ENSP00000409180.1 | |||
ARSD | ENST00000495294.1 | n.751C>A | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000710 AC: 8AN: 112669Hom.: 0 Cov.: 24 AF XY: 0.000115 AC XY: 4AN XY: 34807
GnomAD3 exomes AF: 0.000145 AC: 26AN: 179507Hom.: 0 AF XY: 0.000155 AC XY: 10AN XY: 64631
GnomAD4 exome AF: 0.0000656 AC: 72AN: 1097614Hom.: 0 Cov.: 31 AF XY: 0.0000744 AC XY: 27AN XY: 362998
GnomAD4 genome AF: 0.0000710 AC: 8AN: 112722Hom.: 0 Cov.: 24 AF XY: 0.000115 AC XY: 4AN XY: 34870
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.1616C>A (p.A539D) alteration is located in exon 10 (coding exon 10) of the ARSD gene. This alteration results from a C to A substitution at nucleotide position 1616, causing the alanine (A) at amino acid position 539 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
ARSD-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 01, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at